clariom-transcriptome-profiling-cost-request-950x300

Thank you for submitting your request, you will be contacted shortly.

 

Learn more about transcriptome profiling with our on-demand webinars:

LncRNAs and Breast Cancer Heterogeneity

Initially considered as genomic “junk”, long noncoding RNAs (lncRNAs) have gained attention as critical regulators of coding RNA and alternative splicing. LncRNAs have been associated with tumorigenesis, tumor progression and metastasis, thus emerging as a new class of promising cancer biomarkers and targets for therapeutic agents.

Transcriptome Profiling in Challenging Samples

Extracting robust expression data from clinical research samples represents a unique opportunity to find actionable biomarkers.